Webinar
Capitalizing on Recent Progress to Enhance R&D Efficiency
calendar

May 28, 2025

Calendar
clock

10:00am - 11:00am

GMT

Register

View all IQVIA events

Stabilization and improvement were seen in several key biopharma R&D metrics in 2024, as described in the IQVIA Institute’s Global Trends in R&D 2025 report.

Biopharma funding continued to increase, clinical trial starts and development cycle times stabilized, and R&D program success rates improved.

Sponsors have been employing a variety of efficiency enablers in an effort to improve development speed, success rate and cost.

Enablers such as robust decision-making frameworks and clinical technologies are often employed at an organizational level, while program and trial design factors also play an important role.

In this webinar, we will review recent developments highlighted in the 2025 report and discuss the ongoing opportunities provided by key R&D productivity enablers.

Contact Us